医薬品サードパーティロジスティクスの市場規模、シェア、動向分析レポート：製品別、温度別、治療分野別、メーカー規模別、サービス別、地域別、セグメント予測、2025年～2030年

医薬品サードパーティロジスティクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の医薬品サードパーティロジスティクス市場は、2025年から2030年にかけてCAGR 8.95％で拡大し、2030年には2,285億4,000万米ドルに達する見込みです。

この市場を牽引しているのは、厳しい規制状況、生物製剤や遺伝子治療のような新しい治療法の出現による医薬品流通に関連する課題の増加です。このような複雑さは、多くの製薬会社が社内で不足しているロジスティクスの専門知識を必要とし、研究開発などのコアコンピタンスに集中するためにロジスティクス機能を3PLプロバイダーにアウトソーシングすることを促しています。

さらに、温度管理されたロジスティクスに対する需要の高まりも、市場成長を促す要因の一つとなっています。いくつかの医薬品、特に生物製剤やワクチンは、製造から配送までのサプライチェーン全体を通じて温度管理が要求されます。そのため、こうした温度に敏感な製品の完全性と有効性を確保するには、専門的なコールドチェーン能力が必要となります。こうした要因により、流通プロセス全体を通じて必要な温度条件を維持するための専門知識とインフラを備えた3PLプロバイダーへの需要がさらに高まっています。

さらに、技術の進歩も医薬品ロジスティクスの展望を大きく変えつつあります。ブロックチェーン、モノのインターネット（IoT）、人工知能（AI）などの最先端技術の統合は、サプライチェーンの可視性に革命をもたらし、在庫管理を強化し、出荷のリアルタイム追跡と監視を可能にしています。これらの技術革新により、3PLプロバイダーはロジスティクス業務を最適化し、リスクを最小限に抑え、タイムリーかつ効率的に医薬品を患者に届けることができます。

医薬品3PL市場の主要企業は、競争力を維持し、医薬品業界の進化する需要に対応するため、世界なプレゼンス拡大、コールドチェーン能力の強化、先端技術の統合に戦略的に投資しています。世界の医薬品サプライチェーンの複雑化と温度変化に敏感な製品の輸送増加により、3PLプロバイダーはコールドチェーン物流インフラの強化に取り組んでいます。こうした投資は、温度管理された倉庫や冷蔵輸送など、繊細な医薬品を安全かつ効果的にデリバリーするための最新設備の確立に重点を置いています。例えば、DHLサプライチェーンは2024年2月、ライフサイエンスとヘルスケアのロジスティクス業務を拡大するため、2億米ドルを投資すると発表しました。この投資により、温度に敏感な医薬品の取り扱いにおけるDHLの能力が強化され、コールドチェーンロジスティクスとコンプライアンスが改善されます。

医薬品サードパーティロジスティクス市場レポートハイライト

• 製品別では、製剤の進歩や革新的な治療法の増加により、ブランド医薬品が市場を席巻。製薬会社は複雑な疾患に対する標的治療を常に開発しており、これが同分野の成長に寄与しています。
• 温度別では、常温が2024年に最大の市場シェアを占めました。幅広い医薬品が保管や輸送に温度管理された環境を必要としないからです。
• 治療分野別では、がん領域が2024年に最大の市場シェアを占めました。同分野の市場は、世界のがん罹患率の増加と、生物学的製剤や標的療法を含む専門的治療に対する需要の高まりにより拡大すると予測されます。
• メーカー規模別では、大手が2024年に最大の市場シェアを占めました。これは主に、大規模な生産能力、大規模な流通網、高度なロジスティクス・ソリューションに投資する豊富な資金力によるものです。
• サービス別では、保管と出荷が2024年に最大の市場シェアを占めました。これは、温度に敏感な医薬品を含む医薬品の安全で信頼性の高い保管と効率的な輸送に対する重要なニーズによるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場見通し
• 市場動向と展望
• 市場力学
  • 市場ドライバー分析
  • 市場抑制要因分析
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 医薬品サードパーティロジスティクス（3PL）サービス市場：製品推定・動向分析

• セグメントダッシュボード
• 医薬品サードパーティロジスティクス（3PL）サービス市場：製品変動分析
• 医薬品サードパーティロジスティクス（3PL）サービスの規模と動向分析、製品別、2018～2030年
• ブランド
• ジェネリック
• バイオシミラー
• ワクチン
• 細胞療法
• 遺伝子治療
• その他

第5章 医薬品サードパーティロジスティクス（3PL）サービス市場：温度推定・動向分析

• セグメントダッシュボード
• 医薬品サードパーティロジスティクス（3PL）サービス市場：温度変動分析
• 医薬品サードパーティロジスティクス（3PL）サービスの規模と動向分析、温度別、2018～2030年
• アンビエント
• 冷蔵
• 冷凍
• 超冷凍 / 急速冷凍
• 極低温

第6章 医薬品サードパーティロジスティクス（3PL）サービス市場：治療分野の推定・動向分析

• セグメントダッシュボード
• 医薬品サードパーティロジスティクス（3PL）サービス市場：治療分野の変動分析
• 医薬品サードパーティロジスティクス（3PL）サービスの規模と動向分析、治療分野別、2018～2030年
• 腫瘍学
• 心血管疾患
• 感染症
• 神経学
• 糖尿病
• 腎臓学
• リウマチ学
• アレルギー/喘息
• 消化器内科
• 眼科
• その他

第7章 医薬品サードパーティロジスティクス（3PL）サービス市場：メーカー規模の推定・動向分析

• セグメントダッシュボード
• 医薬品サードパーティロジスティクス（3PL）サービス市場：メーカー規模の変動分析
• 医薬品サードパーティロジスティクス（3PL）サービスの規模と動向分析、メーカー規模別、2018～2030年
• 大
• 中
• 小

第8章 医薬品サードパーティロジスティクス（3PL）サービス市場：サービス推定・動向分析

• セグメントダッシュボード
• 医薬品サードパーティロジスティクス（3PL）サービス市場：サービス変動分析
• 医薬品サードパーティロジスティクス（3PL）サービスの規模と動向分析、サービス別、2018年から2030年
• 保管と配送
• 受注から入金まで
• タイトルモデル
• DSCSAおよびシリアル化サービス
• 医薬品サンプル
• その他

第9章 地域ビジネス分析

• 地域ダッシュボード
• 市場規模と予測および動向分析、2018年から2030年
• 北米
  • 北米の医薬品サードパーティロジスティクス市場、2018年～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州医薬品サードパーティロジスティクス市場、2018年～2030年
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋地域の医薬品サードパーティロジスティクス市場、2018年～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ラテンアメリカの医薬品サードパーティロジスティクス市場、2018年～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ医薬品サードパーティロジスティクス市場、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 企業分類
• 企業市況分析、2024年
• 企業プロファイル
  • CEVA Logistics
  • Cencora Corporation（ICS）
  • DB SCHENKER
  • Kuehne+Nagel
  • Kerry Logistics Network Limited
  • Cardinal Health
  • McKesson Corporation
  • EVERSANA.
  • Thermo Fisher Scientific Inc.
  • Knipper Health

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 4 Global Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 5 Global Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 6 Global Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 7 Global Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 8 Global Pharmaceutical Third-party Logistics (3PL) Market, by Region, 2018 - 2030 (USD Million)
• Table 9 North America Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
• Table 10 North America Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 11 North America Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 12 North America Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 13 North America Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 14 North America Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 15 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 16 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 17 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 18 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 19 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 20 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 21 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 22 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 23 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 24 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 25 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 26 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 27 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 28 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 29 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 30 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
• Table 31 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 32 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 33 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 34 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 35 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 36 UK Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 37 UK Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 38 UK Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 39 UK Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 40 UK Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 41 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 42 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 43 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 44 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 45 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 46 France Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 47 France Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 48 France Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 49 France Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 50 France Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 51 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 52 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 53 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 54 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 55 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 56 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 57 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 58 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 59 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 60 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 61 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 62 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 63 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 64 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 65 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 66 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 67 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 68 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 69 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 70 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 71 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 72 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 73 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 74 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 75 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 78 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 80 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 81 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 82 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 83 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 84 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 85 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 86 China Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 87 China Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 88 China Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 89 China Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 90 China Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 91 India Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 92 India Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 93 India Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 94 India Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 95 India Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 96 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 97 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 98 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 99 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 100 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 101 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 102 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 103 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 104 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 105 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 106 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 107 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 108 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 109 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 110 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 111 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
• Table 112 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 113 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 114 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 115 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 116 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 117 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 118 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 119 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 120 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 121 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 122 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 123 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 124 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 125 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 126 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
• Table 127 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 128 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 129 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 130 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 131 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 132 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 133 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 134 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 135 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 136 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 137 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 138 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 141 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 142 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 143 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 144 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 145 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
• Table 146 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
• Table 147 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
• Table 148 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 149 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
• Table 150 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Pharmaceutical Third-party Logistics (3PL) Market Segmentation
• Fig. 7 Market Snapshot, 2024
• Fig. 8 Market Trends & Outlook
• Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Global Pharmaceutical Third-party Logistics (3PL) Market: Product Key Takeaways
• Fig. 14 Global Pharmaceutical Third-party Logistics (3PL) Market: Product Movement Analysis
• Fig. 15 Global Pharmaceutical Third-party Logistics (3PL) Market, for Branded, 2018 - 2030 (USD Million)
• Fig. 16 Global Pharmaceutical Third-party Logistics (3PL) Market, for Generic, 2018 - 2030 (USD Million)
• Fig. 17 Global Pharmaceutical Third-party Logistics (3PL) Market, for Biosimilar, 2018 - 2030 (USD Million)
• Fig. 18 Global Pharmaceutical Third-party Logistics (3PL) Market, for Vaccine, 2018 - 2030 (USD Million)
• Fig. 19 Global Pharmaceutical Third-party Logistics (3PL) Market, for Cell Therapy, 2018 - 2030 (USD Million)
• Fig. 20 Global Pharmaceutical Third-party Logistics (3PL) Market, for Gene Therapy, 2018 - 2030 (USD Million)
• Fig. 21 Global Pharmaceutical Third-party Logistics (3PL) Market, for Others, 2018 - 2030 (USD Million)
• Fig. 22 Global Pharmaceutical Third-party Logistics (3PL) Market: Temperature Key Takeaways
• Fig. 23 Global Pharmaceutical Third-party Logistics (3PL) Market: Temperature Movement Analysis
• Fig. 24 Global Pharmaceutical Third-party Logistics (3PL) Market, for Ambient, 2018 - 2030 (USD Million)
• Fig. 25 Global Pharmaceutical Third-party Logistics (3PL) Market, for Refrigerated, 2018 - 2030 (USD Million)
• Fig. 26 Global Pharmaceutical Third-party Logistics (3PL) Market, for Frozen, 2018 - 2030 (USD Million)
• Fig. 27 Global Pharmaceutical Third-party Logistics (3PL) Market, for Ultra-frozen/Deep-Frozen, 2018 - 2030 (USD Million)
• Fig. 28 Global Pharmaceutical Third-party Logistics (3PL) Market, for Cryogenic, 2018 - 2030 (USD Million)
• Fig. 29 Global Pharmaceutical Third-party Logistics (3PL) Market: Therapeutic Area Key Takeaways
• Fig. 30 Global Pharmaceutical Third-party Logistics (3PL) Market, Therapeutic Area Movement Analysis
• Fig. 31 Global Pharmaceutical Third-party Logistics (3PL) Market, for Oncology, 2018 - 2030 (USD Million)
• Fig. 32 Global Pharmaceutical Third-party Logistics (3PL) Market, for cardiovascular diseases, 2018 - 2030 (USD Million)
• Fig. 33 Global Pharmaceutical Third-party Logistics (3PL) Market, for Infectious Diseases, 2018 - 2030 (USD Million)
• Fig. 34 Global Pharmaceutical Third-party Logistics (3PL) Market, for Neurology, 2018 - 2030 (USD Million)
• Fig. 35 Global Pharmaceutical Third-party Logistics (3PL) Market, for Diabetes, 2018 - 2030 (USD Million)
• Fig. 36 Global Pharmaceutical Third-party Logistics (3PL) Market, for Nephrology, 2018 - 2030 (USD Million)
• Fig. 37 Global Pharmaceutical Third-party Logistics (3PL) Market, for Rheumatology, 2018 - 2030 (USD Million)
• Fig. 38 Global Pharmaceutical Third-party Logistics (3PL) Market, for Allergy/Asthma, 2018 - 2030 (USD Million)
• Fig. 39 Global Pharmaceutical Third-party Logistics (3PL) Market, for Gastroenterology, 2018 - 2030 (USD Million)
• Fig. 40 Global Pharmaceutical Third-party Logistics (3PL) Market, for Ophthalmology, 2018 - 2030 (USD Million)
• Fig. 41 Global Pharmaceutical Third-party Logistics (3PL) Market, for Others, 2018 - 2030 (USD Million)
• Fig. 42 Global Pharmaceutical Third-party Logistics (3PL) Market: Manufacturer Size Key Takeaways
• Fig. 43 Global Pharmaceutical Third-party Logistics (3PL) Market, Manufacturer Size Movement Analysis
• Fig. 44 Global Pharmaceutical Third-party Logistics (3PL) Market, for Large, 2018 - 2030 (USD Million)
• Fig. 45 Global Pharmaceutical Third-party Logistics (3PL) Market, for Medium, 2018 - 2030 (USD Million)
• Fig. 46 Global Pharmaceutical Third-party Logistics (3PL) Market, for Small, 2018 - 2030 (USD Million)
• Fig. 47 Global Pharmaceutical Third-party Logistics (3PL) Market: Service Key Takeaways
• Fig. 48 Global Pharmaceutical Third-party Logistics (3PL) Market, Service Movement Analysis
• Fig. 49 Global Pharmaceutical Third-party Logistics (3PL) Market, for Storage and Shipping, 2018 - 2030 (USD Million)
• Fig. 50 Global Pharmaceutical Third-party Logistics (3PL) Market, for Order-to-cash, 2018 - 2030 (USD Million)
• Fig. 51 Global Pharmaceutical Third-party Logistics (3PL) Market, for Title Model, 2018 - 2030 (USD Million)
• Fig. 52 Global Pharmaceutical Third-party Logistics (3PL) Market, for DSCSA and Serialization Services, 2018 - 2030 (USD Million)
• Fig. 53 Global Pharmaceutical Third-party Logistics (3PL) Market, for Pharmaceutical Sampling, 2018 - 2030 (USD Million)
• Fig. 54 Global Pharmaceutical Third-party Logistics (3PL) Market, for Others, 2018 - 2030 (USD Million)
• Fig. 55 Regional Marketplace: Key Takeaways
• Fig. 56 Regional Outlook, 2024 & 2030
• Fig. 57 North America Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 58 Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 59 Canada Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 60 Mexico Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 61 Europe Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 62 Germany Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 63 UK Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 64 France Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 65 Italy Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 66 Spain Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 67 Denmark Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 68 Sweden Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 69 Norway Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 70 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 71 Japan Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 72 China Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 73 India Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 74 Australia Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 75 South Korea Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 76 Thailand Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 77 Latin America Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 78 Brazil Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 79 Argentina Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 80 Middle East and Africa Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 81 South Africa Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 82 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 83 UAE Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
• Fig. 84 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)

Pharmaceutical Third-Party Logistics Market Growth & Trends:

The global pharmaceutical third-party logistics market is expected to reach USD 228.54 billion by 2030, expanding at a CAGR of 8.95% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven due to stringent regulatory landscapes, and the emergence of novel therapies like biologics and gene therapies which have increased the challenges associated with drug distribution. This complexity requires specialized logistics expertise that many pharmaceutical companies lack internally, encouraging them to outsource logistics functions to 3PL providers to concentrate on their core competencies, such as research and development.

Furthermore, growing demand for temperature-controlled logistics is also one of the factors driving market growth. Several pharmaceutical products, particularly biologics and vaccines, demand temperature control throughout the entire supply chain, from manufacturing to the point of delivery. Thus, to ensure the integrity and efficacy of these temperature-sensitive products necessitates specialized cold chain capabilities. These factors are further driving the demand for 3PL providers with the expertise and infrastructure to maintain the required temperature conditions throughout the entire distribution process.

In addition, technological advancements are also transforming the pharmaceutical logistics landscape. The integration of cutting-edge technologies such as blockchain, the Internet of Things (IoT), and artificial intelligence (AI) is revolutionizing supply chain visibility, enhancing inventory management, and enabling real-time tracking and monitoring of shipments. These technological innovations empower 3PL providers to optimize logistics operations, minimize risks, and ensure timely and efficient delivery of pharmaceuticals to patients.

Key players in the pharmaceutical 3PL market are strategically investing in expanding their global presence, enhancing their cold chain capabilities, and integrating advanced technologies to maintain a competitive edge and meet the evolving demands of the pharmaceutical industry. The increasing complexity of global pharmaceutical supply chains and the rise in the transportation of temperature-sensitive products, have prompted 3PL providers to strengthen their cold chain logistics infrastructure. These investments focus on establishing state-of-the-art facilities, such as temperature-controlled warehouses and refrigerated transport, to ensure the safe and effective delivery of sensitive drugs. For instance, in February 2024, DHL supply chain announced to invest USD 200 million which aims to expand life sciences and healthcare logistics operations. This investment will enhance DHL's capabilities in handling temperature-sensitive pharmaceutical products, improving cold chain logistics and compliance.

Pharmaceutical Third-Party Logistics Market Report Highlights:

• Based on Product, branded dominated the market due to advancements in drug formulations and the increasing availability of innovative therapies. Pharmaceutical companies are constantly developing targeted treatments for complex diseases which are contributing to the segment growth.
• Based on the temperature, ambient held the largest market share in 2024, as a wide range of pharmaceutical products do not require temperature-controlled environments for storage and transportation.
• Based on the therapeutic area, oncology held the largest market share in 2024. The market for the segment is projected to expand due to the increasing prevalence of cancer worldwide and the growing demand for specialized treatments, including biologics and targeted therapies.
• Based on the manufacturer size, large held the largest market share in 2024. This is primarily due to their extensive production capabilities, larger distribution networks, and greater financial resources to invest in advanced logistics solutions.
• Based on the service, storage and shipping held the largest market share in 2024. This is due to the critical need for secure, reliable storage and efficient transportation of pharmaceutical products, including temperature-sensitive drugs.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Temperature Segment
  • 1.2.3. Therapeutic Area Segment
  • 1.2.4. Manufacturer Size Segment
  • 1.2.5. Service Segment
• 1.3. Information Analysis
  • 1.3.1. Market Formulation & Data Visualization
• 1.4. Data Validation & Publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. The Rise of E-Commerce
    • 3.3.1.2. Growing Demand for Outsourcing Services
    • 3.3.1.3. Rising Demand for Cold Chain Logistics
    • 3.3.1.4. Growing Applications of Reverse Logistics in Biopharmaceutical Industry
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. High Operational Costs
    • 3.3.2.2. Compliance Issues While Outsourcing
• 3.4. Industry Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
  • 3.4.2. PESTEL Analysis
  • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Third-Party Logistics (3PL) Services Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Product Movement Analysis
• 4.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Branded
  • 4.4.1. Branded market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Generic
  • 4.5.1. Generic market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Biosimilar
  • 4.6.1. Biosimilar market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Vaccine
  • 4.7.1. Vaccine market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Cell Therapy
  • 4.8.1. Cell therapy market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Gene Therapy
  • 4.9.1. Gene therapy market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Others
  • 4.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Pharmaceutical Third-Party Logistics (3PL) Services Market: Temperature Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Temperature Movement Analysis
• 5.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Temperature, 2018 to 2030 (USD Million)
• 5.4. Ambient
  • 5.4.1. Ambient market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Refrigerated
  • 5.5.1. Refrigerated market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Frozen
  • 5.6.1. Frozen market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Ultra-frozen/Deep-Frozen
  • 5.7.1. Ultra-frozen/Deep-Frozen market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Cryogenic
  • 5.8.1. Cryogenic market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Pharmaceutical Third-Party Logistics (3PL) Services Market: Therapeutic Area Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Therapeutic Area Movement Analysis
• 6.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
• 6.4. Oncology
  • 6.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Cardiovascular Diseases
  • 6.5.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Infectious Diseases
  • 6.6.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Neurology
  • 6.7.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Diabetes
  • 6.8.1. Diabetes market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. Nephrology
  • 6.9.1. Nephrology market estimates and forecasts 2018 to 2030 (USD Million)
• 6.10. Rheumatology
  • 6.10.1. Rheumatology market estimates and forecasts 2018 to 2030 (USD Million)
• 6.11. Allergy/Asthma
  • 6.11.1. Allergy/Asthma market estimates and forecasts 2018 to 2030 (USD Million)
• 6.12. Gastroenterology
  • 6.12.1. Gastroenterology market estimates and forecasts 2018 to 2030 (USD Million)
• 6.13. Ophthalmology
  • 6.13.1. Ophthalmology market estimates and forecasts 2018 to 2030 (USD Million)
• 6.14. Others
  • 6.14.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Pharmaceutical Third-Party Logistics (3PL) Services Market: Manufacturer Size Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Manufacturer Size Movement Analysis
• 7.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Manufacturer Size, 2018 to 2030 (USD Million)
• 7.4. Large
  • 7.4.1. Large market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Medium
  • 7.5.1. Medium market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Small
  • 7.6.1. Small market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Pharmaceutical Third-Party Logistics (3PL) Services Market: Service Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Service Movement Analysis
• 8.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
• 8.4. Storage and Shipping
  • 8.4.1. Storage and Shipping market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Order-to-cash
  • 8.5.1. Order-to-cash market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Title Model
  • 8.6.1. Title Model market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. DSCSA and Serialization Services
  • 8.7.1. DSCSA and Serialization Services market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Pharmaceutical Sampling
  • 8.8.1. Pharmaceutical Sampling market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. Others
  • 8.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Regional Business Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 9.3. North America
  • 9.3.1. North America Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Framework
    • 9.3.2.4. U.S. Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Framework
    • 9.3.3.4. Canada Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Framework
    • 9.3.4.4. Mexico Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Framework
    • 9.4.2.4. Germany Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.4.3. UK
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Framework
    • 9.4.3.4. UK Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Framework
    • 9.4.4.4. France Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Framework
    • 9.4.5.4. Italy Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Framework
    • 9.4.6.4. Spain Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Framework
    • 9.4.7.4. Denmark Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Framework
    • 9.4.8.4. Sweden Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Framework
    • 9.4.9.4. Norway Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Japan Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. China Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. India Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Framework
    • 9.5.5.4. South Korea Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.5.6. Australia
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Framework
    • 9.5.6.4. Australia Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.5.7. Thailand
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Framework
    • 9.5.7.4. Thailand Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Brazil Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Argentina Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. South Africa Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. Saudi Arabia Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. UAE Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Kuwait Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company Categorization
• 10.2. Company Market Position Analysis, 2024
• 10.3. Company Profiles
  • 10.3.1. CEVA Logistics
    • 10.3.1.1. Company overview
    • 10.3.1.2. Financial performance
    • 10.3.1.3. Service benchmarking
    • 10.3.1.4. Strategic initiatives
  • 10.3.2. Cencora Corporation (ICS)
    • 10.3.2.1. Company overview
    • 10.3.2.2. Financial performance
    • 10.3.2.3. Service benchmarking
    • 10.3.2.4. Strategic initiatives
  • 10.3.3. DB SCHENKER
    • 10.3.3.1. Company overview
    • 10.3.3.2. Financial performance
    • 10.3.3.3. Service benchmarking
    • 10.3.3.4. Strategic initiatives
  • 10.3.4. Kuehne+Nagel
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Service benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. Kerry Logistics Network Limited
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Service benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Cardinal Health
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Service benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. McKesson Corporation
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Service benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. EVERSANA.
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Service benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. Thermo Fisher Scientific Inc.
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Service benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Knipper Health
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Service benchmarking
    • 10.3.10.4. Strategic initiatives